Posted by Michael Wonder on 03 Sep 2018
Dutch doctors fight pharma company’s 500 fold drug price rise
3 September 2018 - Regulator urged to probe Leadiant Biosciences’ alleged abuse of market power.
A group of Dutch doctors and health advocates are taking action against an Italian pharmaceutical company, which has pushed through a 500-fold price increase of a life-saving drug.
The Dutch Pharmaceutical Accountability Foundation, a non-profit group set up to tackle high drug prices, is set to file a claim this week with The Netherlands’ Authority for Consumers and Markets to probe alleged abuse of market power by Leadiant Biosciences over its drug chenodeoxycholic acid.
